Here you will find the recommendations we have made about the use of individual medicines in Lancashire.


Brand: Orencia┬«
Indication: LMMG RA Biologic Pathway (with Methotrexate where patient has moved through pathway to 3rd line and tocilizumab is contraindicated, withdrawn due to adverse effect, or has been used earlier in treatment pathway)
Disease category: Musculoskeletal and joint diseases
Commissioning responsibility: CCG
PbR excluded: Yes


LMMG recommends the use of abatacept when 3rd line tocilizumab is contraindicated, or is withdrawn due to adverse events, or has been used earlier in the treatment pathway.


LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

Rheumatoid Arthritis Pathway (Version 3.0) (101.4 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG